Mirati Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Mirati Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q4 2022.
  • Mirati Therapeutics, Inc. Operating Lease, Liability for the quarter ending December 31, 2022 was $51.5M, a 12.2% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $51.5M +$5.6M +12.2% Dec 31, 2022 10-Q 2023-05-09
Q4 2021 $45.9M +$4M +9.55% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $41.9M +$41.2M +5886% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $700K Dec 31, 2019 10-K 2021-02-25
Q2 2019 $200K Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $300K Mar 31, 2019 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.